Boxer Capital as of March 31, 2018
Portfolio Holdings for Boxer Capital
Boxer Capital holds 33 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Avexis | 11.9 | $111M | 900k | 123.58 | |
| Beigene (ONC) | 11.3 | $106M | 630k | 168.00 | |
| Ptc Therapeutics I (PTCT) | 7.5 | $70M | 2.6M | 26.99 | |
| Esperion Therapeutics (ESPR) | 7.0 | $65M | 900k | 72.33 | |
| Odonate Therapeutics Ord | 6.4 | $60M | 2.8M | 21.18 | |
| Macrogenics (MGNX) | 5.9 | $55M | 2.2M | 25.16 | |
| Wave Life Sciences (WVE) | 5.8 | $54M | 1.4M | 40.05 | |
| Loxo Oncology | 4.9 | $46M | 400k | 115.37 | |
| Mirati Therapeutics | 4.5 | $42M | 1.4M | 30.70 | |
| Medicines Company | 4.4 | $41M | 1.3M | 32.94 | |
| Rocket Pharmaceuticals (RCKT) | 3.9 | $37M | 2.0M | 18.75 | |
| Cymabay Therapeutics | 3.8 | $35M | 2.7M | 12.99 | |
| Gtx Inc Del | 3.0 | $28M | 1.6M | 17.75 | |
| G1 Therapeutics | 2.6 | $25M | 660k | 37.05 | |
| Dbv Technologies S A | 2.5 | $24M | 1.0M | 23.07 | |
| Blueprint Medicines (BPMC) | 2.5 | $23M | 250k | 91.70 | |
| Rigel Pharmaceuticals | 1.9 | $18M | 5.1M | 3.54 | |
| Kura Oncology (KURA) | 1.7 | $16M | 845k | 18.75 | |
| Viking Therapeutics (VKTX) | 1.5 | $14M | 3.2M | 4.37 | |
| Ionis Pharmaceuticals (IONS) | 1.5 | $14M | 312k | 44.08 | |
| Aquinox Pharmaceuticals | 1.1 | $11M | 748k | 14.08 | |
| La Jolla Pharmaceuticl Com Par | 0.8 | $8.0M | 268k | 29.78 | |
| Reata Pharmaceuticals Inc Cl A | 0.7 | $6.7M | 325k | 20.51 | |
| Sunesis Pharmaceuticals Inc Ne | 0.6 | $5.8M | 2.1M | 2.72 | |
| Solid Biosciences | 0.6 | $5.6M | 750k | 7.50 | |
| Dermira | 0.4 | $4.0M | 500k | 7.99 | |
| Bellerophon Therapeutics | 0.4 | $3.9M | 1.9M | 2.08 | |
| Bellicum Pharma | 0.2 | $2.3M | 350k | 6.56 | |
| Rigel Pharmaceuticals Inc cmn | 0.2 | $1.8M | 500k | 3.54 | |
| Novus Therapeutics | 0.2 | $1.6M | 324k | 5.04 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $1.4M | 100k | 14.23 | |
| Regulus Therapeutics | 0.1 | $1.2M | 1.7M | 0.72 | |
| Onconova Therapeutics Inc *w exp 07/07/202 | 0.0 | $73k | 242k | 0.30 |
